Since the COVID-19 pandemic, delays and refusals of well-established childhood vaccines have been observed in some settings, coinciding with resurgences of preventable infectious diseases. Concern exists that hesitancy surrounding COVID-19 vaccines could extend to acceptance of future novel pediatric vaccines. This study examined caregiver perceptions of novel childhood vaccinations and intentions to vaccinate adolescents aged 12–17 years against COVID-19 in Lusaka, Zambia.
This analysis is a secondary evaluation of a larger cross-sectional survey administered to parents and caregivers of children aged 0–17 years in Lusaka between 13 November and 15 December 2023. The analytic sample included 277 caregivers; caregiver characteristics collected included age, sex, caregiver role (community member or healthcare worker), personal COVID-19 vaccination status, and their children’s routine vaccination histories.
Vaccination intention questions focused on adolescents 12–17 years given contemporaneous COVID-19 vaccination guidelines for that age group. Descriptive statistics were used to summarize demographic features, vaccination history, and caregivers’ perceptions of COVID-19 and potential future novel vaccines for children.
Participant characteristics: of 277 caregivers, 66.8% were women and the median caregiver age was 35 years. The sample included both community caregivers and healthcare workers (HCWs).
Routine immunization history: overall, 93.1% of caregivers reported that their child had received all recommended routine childhood vaccinations, indicating high reported uptake of standard pediatric immunizations.
Caregiver COVID-19 vaccination and adolescent uptake: COVID-19 vaccine uptake among caregivers varied by role. HCWs reported higher COVID-19 vaccine coverage, with 68.2% having received two or more doses, compared with 40.8% of community caregivers. Among adolescents aged 12–17 years, 58.0% of caregivers reported their adolescent had received at least one COVID-19 vaccine dose. The analysis found an association between caregiver vaccination status and adolescent uptake: caregivers with two or more COVID-19 doses were more likely to report that their adolescents had been vaccinated.
Intention to vaccinate children further against COVID-19: despite moderate adolescent vaccination coverage, the overall intention to additionally vaccinate children against COVID-19 was low. Notably, 24.7% of caregivers indicated they had no intention to vaccinate their children further; intention was particularly low among caregivers whose children were not yet vaccinated.
Motivations for accepting future novel childhood vaccines: when asked about potential novel vaccines for children against diseases such as malaria, TB, HIV, pneumonia, influenza, and diarrheal diseases, the most commonly cited reason for intending to vaccinate was protection from hospitalization and death. This rationale was endorsed by 79.1% of caregivers indicating acceptance of novel vaccines.
Concerns driving reluctance: the leading reasons caregivers gave for reluctance toward future vaccines were fear of potential side effects (45.5%) and insufficient knowledge about the benefits and risks of vaccination (31.8%). These concerns indicate safety perceptions and information gaps as principal barriers to uptake of novel pediatric vaccines.
Caregivers reported high levels of trust in specific information sources. The Ministry of Health was the most trusted source, identified by 86.6% of respondents, followed by healthcare professionals at 66.8%. These findings highlight institutional and clinical channels as preferred and credible avenues for communication about vaccines.
In this Lusaka-based sample, reported coverage of routine childhood vaccinations remained high. However, acceptance of COVID-19 vaccines for adolescents and openness to future novel pediatric vaccines were lower. Caregivers’ own COVID-19 vaccination status was associated with adolescent uptake, suggesting caregiver behavior and beliefs influence decisions for children.
Key barriers identified were concerns about side effects and lack of knowledge about vaccine benefits and risks. Given caregivers’ strong trust in the Ministry of Health and healthcare professionals, the authors suggest that targeted, transparent communication delivered through these trusted channels may be critical to address safety concerns and strengthen confidence in novel childhood vaccines.
Limitations and additional details: specific statistical measures, adjusted analyses, sampling strategy details beyond the dates and sample size, and full questionnaire items were not reported in the abstract. The study is a preprint and has not been peer reviewed; findings should be interpreted accordingly.